UNSPSC 51273928: Dextrose/epinephrine/tetracaine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN204. This VA Drug Class (CN204) classifies this compound as belonging to the group LOCAL ANESTHETICS, INJECTION.

UNSPSC 51273928 Dextrose/epinephrine/tetracaine is a Commodity code that covers emergency pharmaceuticals and related medical supplies procured by state and local public health agencies, primarily for community health initiatives, opioid response programs, and pharmacy benefit management. State and local governments under this code are acquiring naloxone, drug deactivation systems, generic multi-source pharmaceuticals, and over-the-counter products through competitive bidding and cooperative purchasing arrangements. Issuing bodies include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS Commission), and cooperative purchasing alliances serving multiple jurisdictions (Minnesota Multistate Cooperative Purchasing Alliance administering contracts across Minnesota and Oregon). These procurements reflect the increasing focus on emergency response capability and cost-effective pharmaceutical distribution across state and local health systems.

Recent activity shows geographic spread across Florida, Texas, Minnesota, and Oregon, with the most visible concentration in multi-state cooperative purchasing vehicles. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, response due July 26, 2023. The Texas HHS Commission issued RFI HHS0017013 in April 2026 to solicit vendor capabilities for a direct-to-manufacturer prescription program, an exploratory notice designed to inform future formal procurement strategy. The Minnesota Department of Administration's Office of State Procurement, administering the MMCAP cooperative, issued an RFP in January 2026 for generic multi-source pharmaceuticals and OTC products with a March 26, 2026 response deadline and July 1, 2026 contract effective date, requiring manufacturers to supply through three authorized wholesalers and comply with cGMP and Drug Supply Chain Security Act certification. Vendors in all three solicitations must meet federal compliance requirements, including E-Verify employment verification and, where FEMA funding applies, adherence to environmental and federal procurement regulations.